He's Handled More ANDA Cases Than Anyone, And Now He's Retiring: Judge Sleet Reflects On His Career
Executive Summary
In an interview with the Pink Sheet, Delaware District Judge Sleet discusses patent reform fallout and major issues facing district courts.
You may also be interested in...
Hemophilia Patients Call For US FDA Hearing To Assure Access To Hemlibra
Patients submit citizen petition in response to Shire's request for preliminary injunction in patent dispute with Genentech, calling it a clear example of 'gaming the system.'
Biosimilar Suits: Another Court To Rule On Declaratory Judgement Timing
Infringement suits have become routine, but Amgen’s, Celltrion’s and Teva’s suits against Genentech’s patents illustrate new trend by biosimilar sponsors to seek declaratory judgements of noninfringement.
Biopharma Patent Disputes: Upheaval Likely As US Supreme Court Limits Litigation Venue
Decision requiring suits to be filed in state where defendant is incorporated may deter consolidation of ANDA suits and increase venue fights; Court to hear challenge to PTAB inter partes review process.